These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 19189648

  • 1. Green tea catechin inhibits fatty acid synthase without stimulating carnitine palmitoyltransferase-1 or inducing weight loss in experimental animals.
    Puig T, Relat J, Marrero PF, Haro D, Brunet J, Colomer R.
    Anticancer Res; 2008; 28(6A):3671-6. PubMed ID: 19189648
    [Abstract] [Full Text] [Related]

  • 2. Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75.
    Puig T, Vázquez-Martín A, Relat J, Pétriz J, Menéndez JA, Porta R, Casals G, Marrero PF, Haro D, Brunet J, Colomer R.
    Breast Cancer Res Treat; 2008 Jun; 109(3):471-9. PubMed ID: 17902053
    [Abstract] [Full Text] [Related]

  • 3. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
    Pan MH, Lin CC, Lin JK, Chen WJ.
    J Agric Food Chem; 2007 Jun 27; 55(13):5030-7. PubMed ID: 17539658
    [Abstract] [Full Text] [Related]

  • 4. Novel anti-fatty acid synthase compounds with anti-cancer activity in HER2+ breast cancer.
    Oliveras G, Blancafort A, Urruticoechea A, Campuzano O, Gómez-Cabello D, Brugada R, López-Rodríguez ML, Colomer R, Puig T.
    Ann N Y Acad Sci; 2010 Oct 27; 1210():86-92. PubMed ID: 20973802
    [Abstract] [Full Text] [Related]

  • 5. New synthetic inhibitors of fatty acid synthase with anticancer activity.
    Turrado C, Puig T, García-Cárceles J, Artola M, Benhamú B, Ortega-Gutiérrez S, Relat J, Oliveras G, Blancafort A, Haro D, Marrero PF, Colomer R, López-Rodríguez ML.
    J Med Chem; 2012 Jun 14; 55(11):5013-23. PubMed ID: 22559865
    [Abstract] [Full Text] [Related]

  • 6. Novel Inhibitors of Fatty Acid Synthase with Anticancer Activity.
    Puig T, Turrado C, Benhamú B, Aguilar H, Relat J, Ortega-Gutiérrez S, Casals G, Marrero PF, Urruticoechea A, Haro D, López-Rodríguez ML, Colomer R.
    Clin Cancer Res; 2009 Dec 15; 15(24):7608-7615. PubMed ID: 20008854
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis.
    Menendez JA, Colomer R, Lupu R.
    Med Hypotheses; 2005 Dec 15; 64(2):337-41. PubMed ID: 15607568
    [Abstract] [Full Text] [Related]

  • 8. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
    Tang Y, Zhao DY, Elliott S, Zhao W, Curiel TJ, Beckman BS, Burow ME.
    Int J Oncol; 2007 Oct 15; 31(4):705-11. PubMed ID: 17786300
    [Abstract] [Full Text] [Related]

  • 9. Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice.
    Lee MS, Kim CT, Kim Y.
    Ann Nutr Metab; 2009 Oct 15; 54(2):151-7. PubMed ID: 19390166
    [Abstract] [Full Text] [Related]

  • 10. Analyzing effects of extra-virgin olive oil polyphenols on breast cancer-associated fatty acid synthase protein expression using reverse-phase protein microarrays.
    Menendez JA, Vazquez-Martin A, Oliveras-Ferraros C, Garcia-Villalba R, Carrasco-Pancorbo A, Fernandez-Gutierrez A, Segura-Carretero A.
    Int J Mol Med; 2008 Oct 15; 22(4):433-9. PubMed ID: 18813848
    [Abstract] [Full Text] [Related]

  • 11. Different fatty acid metabolism effects of (-)-epigallocatechin-3-gallate and C75 in adenocarcinoma lung cancer.
    Relat J, Blancafort A, Oliveras G, Cufí S, Haro D, Marrero PF, Puig T.
    BMC Cancer; 2012 Jul 06; 12():280. PubMed ID: 22769244
    [Abstract] [Full Text] [Related]

  • 12. Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.
    Zhou W, Simpson PJ, McFadden JM, Townsend CA, Medghalchi SM, Vadlamudi A, Pinn ML, Ronnett GV, Kuhajda FP.
    Cancer Res; 2003 Nov 01; 63(21):7330-7. PubMed ID: 14612531
    [Abstract] [Full Text] [Related]

  • 13. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent.
    Landis-Piwowar KR, Huo C, Chen D, Milacic V, Shi G, Chan TH, Dou QP.
    Cancer Res; 2007 May 01; 67(9):4303-10. PubMed ID: 17483343
    [Abstract] [Full Text] [Related]

  • 14. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells.
    Rieger-Christ KM, Hanley R, Lodowsky C, Bernier T, Vemulapalli P, Roth M, Kim J, Yee AS, Le SM, Marie PJ, Libertino JA, Summerhayes IC.
    J Cell Biochem; 2007 Oct 01; 102(2):377-88. PubMed ID: 17348027
    [Abstract] [Full Text] [Related]

  • 15. Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity.
    Zhang Y, Han G, Fan B, Zhou Y, Zhou X, Wei L, Zhang J.
    Eur J Pharmacol; 2009 Mar 15; 606(1-3):172-9. PubMed ID: 19171136
    [Abstract] [Full Text] [Related]

  • 16. EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells.
    Huang CH, Tsai SJ, Wang YJ, Pan MH, Kao JY, Way TD.
    Mol Nutr Food Res; 2009 Sep 15; 53(9):1156-65. PubMed ID: 19662644
    [Abstract] [Full Text] [Related]

  • 17. Selective inhibition of fatty acid synthase for lung cancer treatment.
    Orita H, Coulter J, Lemmon C, Tully E, Vadlamudi A, Medghalchi SM, Kuhajda FP, Gabrielson E.
    Clin Cancer Res; 2007 Dec 01; 13(23):7139-45. PubMed ID: 18056164
    [Abstract] [Full Text] [Related]

  • 18. Suppression of fatty acid synthase in MCF-7 breast cancer cells by tea and tea polyphenols: a possible mechanism for their hypolipidemic effects.
    Yeh CW, Chen WJ, Chiang CT, Lin-Shiau SY, Lin JK.
    Pharmacogenomics J; 2003 Dec 01; 3(5):267-76. PubMed ID: 12931129
    [Abstract] [Full Text] [Related]

  • 19. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
    Uddin S, Hussain AR, Ahmed M, Abubaker J, Al-Sanea N, Abduljabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Bavi P, Al-Kuraya KS.
    Am J Gastroenterol; 2009 Jul 01; 104(7):1790-801. PubMed ID: 19491830
    [Abstract] [Full Text] [Related]

  • 20. Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1.
    Furuta E, Pai SK, Zhan R, Bandyopadhyay S, Watabe M, Mo YY, Hirota S, Hosobe S, Tsukada T, Miura K, Kamada S, Saito K, Iiizumi M, Liu W, Ericsson J, Watabe K.
    Cancer Res; 2008 Feb 15; 68(4):1003-11. PubMed ID: 18281474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.